{
    "id": 31945,
    "fullName": "PVT1 - RSPO2",
    "impact": "fusion",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "PVT1-RSPO2 results from the fusion of PVT1 and RSPO2 (PMID: 30250044). PVT1-RSPO2 has been identified in colorectal cancer (PMID: 30250044), but has not been biochemically characterized and therefore, the effect on protein function is unknown (PubMed, Jan 2020).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 17432,
                    "pubMedId": 30250044,
                    "title": "Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30250044"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5820,
        "geneSymbol": "PVT1",
        "terms": [
            "PVT1",
            "LINC00079",
            "MIR1204HG",
            "NCRNA00079",
            "onco-lncRNA-100"
        ]
    },
    "variant": "PVT1 - RSPO2",
    "createDate": "01/02/2020",
    "updateDate": "01/02/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 340419,
                "geneSymbol": "RSPO2",
                "terms": [
                    "RSPO2",
                    "CRISTIN2",
                    "HHRRD",
                    "TETAMS2"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 19649,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a patient derived xenograft (PDX) model of colorectal cancer harboring PVT1-RSPO2 demonstrated tumor growth inhibition and reduced Wnt pathway activation when treated with CGX1321 (PMID: 30250044).",
            "molecularProfile": {
                "id": 34379,
                "profileName": "PVT1 - RSPO2"
            },
            "therapy": {
                "id": 6584,
                "therapyName": "CGX1321",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17432,
                    "pubMedId": 30250044,
                    "title": "Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30250044"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34379,
            "profileName": "PVT1 - RSPO2",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}